Wendy's rejects $1.4 billion Trian takeover bid, triggers poison pill
Wendy's rejected a $1. 4 billion cash takeover offer from a Trian Fund Management-led investor group in the United States on November 5, activating a poison-pill defense, CNBC reported. Earlier, on October 26, Trian Fund Management proposed to buy Wendy's at $7.
35 per share in cash, a 20 % premium to the prior closing price, according to CNBC. NBC News said the bid came from Nelson Peltz and that the board formed a committee to review the unsolicited proposal. Fortune noted that Wendy's had endured six straight quarters of declining sales and was seeking to regain market share, making it a target for Trian.